目次
1. Report Overview
1.1 Introduction to Pharma Contract Sales Market
1.2 Global Pharma Contract Sales Market Overview
1.3 What are the Objectives of this Report?
1.4 What is the Scope of the Report?
1.5 Pharma Contract Sales Market Definition
1.6 Why You Should Read This Report
1.7 What This Report Delivers
1.8 Key Questions Answered By This Analytical Report Include:
1.9 Who is This Report for?
1.10 Research Methodology
1.10.1 Primary Research
1.10.2 Secondary Research
1.10.3 Market Evaluation & Forecasting Methodology
1.11 Frequently Asked Questions (FAQs)
1.12 Associated Visiongain Reports
1.13 About Visiongain
2 Executive Summary
3 Pharma Contract Sales Industry Structure
3.1 Overview
3.2 Outsource Pharma Services
3.2.1 Contract Development and Manufacturing Organisations (CDMOs)
3.2.2 Contract Packaging Organisations (CPOs)
3.2.3 Contract Sales Organisations (CSOs)
3.2.4 Serialisation
3.2.5 Contract Research Organisations (CROs)
3.2.6 Contract Development and Manufacturing Organisations (CDMOs)
4 Global Market Dynamics
4.1 Market Driving Factors
4.1.1 Extension Of The Platform
4.1.2 Expertise Shift To Outsourcers
4.1.3 Increased Technological Utilisation
4.2 Market Restraining Factors
4.2.1 Drugs And Clinical Trials Are Becoming More Complex.
4.2.2 Quality Compromise In Pharma Sales Services
4.2.3 Restricts Growth Of The Submarket Of Contract Pharma Sakes API
4.3 Opportunities in the Global Market
4.3.1 Outsourcing Is Becoming More Common Due to Pressures from The Pharmaceutical Industry.
4.3.2 The Pharma Contract Sales Is "All-In-One" Solution
4.3.3 Increased Interest In CRO Services Fuelled By Data
4.4 Challenges in the Global Market
4.4.1 The Need Of Reducing R&D Spending
4.4.2 More Expensive Treatments In The Process
4.4.3 Market Evaluation Challenges: Supply Vs Demand Market
4.5 SWOT Analysis
4.5.1 Strengths
4.5.2 Weakness
4.5.3 Opportunities
4.5.4 Threats
4.6 PEST Analysis
4.6.1 Political
4.6.2 Economical
4.6.3 Sociocultural
4.6.4 Technology
4.7 Porter Five Forces
4.7.1 What is Porter Five (5) Forces
4.7.2 Threat of New Entrants (Low to Moderate)
4.7.3 Rivalry Among the Existing Players (High)
4.7.4 Bargaining Power of Suppliers (Low)
4.7.5 Threats from Substitute Products (Low to Moderate)
4.7.6 Bargaining Power of Buyers (High)
5 Global Pharma Contract Sales Market Analysis
5.1 Global Market Outlook
5.2 Global Market Size Estimation and Forecast
5.2.1 Pre-COVID-19 Market Scenario
5.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
5.3 Regional Market Size Estimation and Forecast
5.3.1 Pre-COVID-19 Market Scenario
5.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Market Size Estimation and Forecast By Type
6.1 Segment Overview
6.1.1 Personal Promotion
6.1.2 Non-Personal Promotion
6.1.3 Co-Promotion
6.2 Pre-COVID-19 Market Scenario
6.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
7 Global Market Size Estimation and Forecast By Personal Promotion
7.1 Commercial Aspects
7.2 Segment Overview
7.2.1 Standard Field Force Roles
7.2.2 Sales Deployment
7.2.3 Vacancy Coverage
7.2.4 Health Care Professional Educational Programs
7.2.5 Key Account Management
7.3 Pre-COVID-19 Market Scenario
7.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
8 Global Market Size Estimation and Forecast By Non- Personal Promotion
8.1 Commercial Aspects
8.2 Segment Overview
8.2.1 Contact Center
8.2.2 Teledetailing
8.2.3 Medical Call Centers
8.2.4 Telesampling
8.2.5 Online Services
8.3 Pre-COVID-19 Market Scenario
8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9 Global Market Size Estimation and Forecast By Co-Promotion
9.1 Commercial Aspects
9.2 Segment Overview
9.2.1 Marketing Research and Consulting
9.2.2 Territory Optimization & Alignment
9.2.3 Brand Management
9.2.4 Mature Product Line Support
9.3 Pre-COVID-19 Market Scenario
9.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10 Global Market Size Estimation and Forecast By Therapeutic
10.1 Commercial Aspects
10.2 Segment Overview
10.2.1 Cardiovascular Disease
10.2.2 Metabolic Disorders
10.2.3 Oncology
10.2.4 Alzheimer's Disease
10.2.5 Diabetes
10.3 Pre-COVID-19 Market Scenario
10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11 North America Market Size Estimation and Forecast
11.1 North America Market Size Estimation and Forecast
11.1.1 Changing Pharmaceutical And Health Industry Dynamics Led To Innovation in the North America Region
11.1.2 Pre-COVID-19 Market Scenario
11.1.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.2 Country Market Size Estimation and Forecast
11.2.1 Pre-COVID-19 Market Scenario
11.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.3 North America Market Size Estimation and Forecast By Type
11.3.1 Pre-COVID-19 Market Scenario
11.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.4 North America Market Size Estimation and Forecast By Personal Promotion
11.4.1 Pre-COVID-19 Market Scenario
11.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.5 North America Market Size Estimation and Forecast By Non- Personal Promotion
11.5.1 Pre-COVID-19 Market Scenario
11.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.6 North America Market Size Estimation and Forecast By Co-Promotion
11.6.1 Pre-COVID-19 Market Scenario
11.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.7 North America Market Size Estimation and Forecast By Therapeutic
11.7.1 Pre-COVID-19 Market Scenario
11.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.8 U.S. Market Analysis
11.8.1 The US is One of the Most Important Pharmaceutical Markets Due to Presence of Largest Pharmaceutical Firms
11.8.2 U.S. Regulations Regarding Contract Sales
11.8.3 Pre-COVID-19 Market Scenario
11.8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.9 Canada Market Analysis
11.9.1 Canada Market Consists Of A Variety Of Sub-Sectors Serving Various Segments Of The Industry
11.9.2 Pharma Sales Are Scattered Among Toronto, Montreal And Vancouver Metropolitan Areas
11.9.3 Pre-COVID-19 Market Scenario
11.9.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.10 Mexico Market Analysis
11.10.1 Mexico With Over 350 Local And Cross-Border Businesses Producing Pharmaceuticals Influence US Market
11.10.2 Pre-COVID-19 Market Scenario
11.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12 Asia-Pacific Market Size Estimation and Forecast
12.1 Asia-Pacific Market Size Estimation and Forecast
12.1.1 The Rise Of Pharma Contract Sales Organisations In The APAC Is Guided By The Changing Market Access, Repayment Policies And Competitive Environment
12.1.2 In Pharmaceutical Investment In The World, Asia Is The Fastest Expanding Region
12.1.3 Pre-COVID-19 Market Scenario
12.1.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.2 Country Market Size Estimation and Forecast
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 Asia-Pacific Market Size Estimation and Forecast By Type
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 Asia-Pacific Market Size Estimation and Forecast By Personal Promotion
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 Asia-Pacific Market Size Estimation and Forecast By Non- Personal Promotion
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 Asia-Pacific Market Size Estimation and Forecast By Co-Promotion
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 Asia-Pacific Market Size Estimation and Forecast By Therapeutic
12.7.1 Pre-COVID-19 Market Scenario
12.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 China Market Analysis
12.8.1 Ever Growing Pharma Industry in China
12.8.2 Driving Element Behind The Tremendous Outsourcing Growth Of China
12.9 Pre-COVID-19 Market Scenario
12.9.1 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.10 India Market Analysis
12.10.1 Strong Foothold of Pharma Companies In India
12.10.2 Evolving Healthcare System in the Country
12.10.3 Pre-COVID-19 Market Scenario
12.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.11 Japan Market Analysis
12.11.1 Steady Pharma Growth and Development In Japan Will Drive Contract Sales Market
12.11.2 Pool of Opportunities in Japan for CSOs
12.11.3 Pre-COVID-19 Market Scenario
12.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.12 South Korea Market Analysis
12.12.1 South Korea Hopes To Win 6% Of Global Pharmaceutical And Medical Device Manufacturing By 2030
12.12.2 Pre-COVID-19 Market Scenario
12.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.13 Australia Market Analysis
12.13.1 Pharmaceutical Market In Australia Represents A Knowledge-Based, Technology-Intensive Industry
12.13.2 Number Of Opportunities Open To Companies Hoping To Invest In The Australian Pharmaceutical Industry
12.13.3 Pre-COVID-19 Market Scenario
12.13.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.14 Rest of Asia-Pacific Market Analysis
12.14.1 More Launches, Increased Payer and Regulatory Scrutiny, And Increased Rivalry Have Resulted In Shorter Sales Cycles In Asia-Pacific
12.14.2 Pre-COVID-19 Market Scenario
12.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13 Europe Market Size Estimation and Forecast
13.1 Region Overview
13.1.1 Outsourced Products Have Grown Beyond Their Original Focus And Now Address A Wide Range Of Company Demands
13.1.2 Europe Is Emerging As Competitive Sources Of Contract Production And Sales Services
13.1.3 Growing Presence of Contract Sales development and manufacturing (CDMOs) companies
13.2 Europe Market Size Estimation and Forecast
13.2.1 Pre-COVID-19 Market Scenario
13.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.3 Country Market Size Estimation and Forecast
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 Europe Market Size Estimation and Forecast By Type
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 Europe Market Size Estimation and Forecast By Personal Promotion
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 Europe Market Size Estimation and Forecast By Non- Personal Promotion
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 Europe Market Size Estimation and Forecast By Co-Promotion
13.7.1 Pre-COVID-19 Market Scenario
13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 Europe Market Size Estimation and Forecast By Therapeutic
13.8.1 Pre-COVID-19 Market Scenario
13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 Germany Market Analysis
13.9.1 Germany Is The World's Largest Market For Biosimilar Pharmaceuticals Creates Opportunities for CSOs
13.9.2 Pre-COVID-19 Market Scenario
13.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 UK Market Analysis
13.10.1 Challenges in the UK Pharmaceutical Market
13.10.2 Pre-COVID-19 Market Scenario
13.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 France Market Analysis
13.11.1 France Is Europe's Third-Largest Market And One Of The Biggest Pharmaceutical Users In The World
13.11.2 Not Every Pharmaceutical Company Prefers Contract Sales In France
13.11.3 Pre-COVID-19 Market Scenario
13.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 Italy Market Analysis
13.12.1 Pharma Contract Sales Is One of the Important Pharma Segment in Italy
13.12.2 Pre-COVID-19 Market Scenario
13.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.13 Spain Market Analysis
13.13.1 Spain's Pharmaceutical Industry Has Always Been One Of Spain's Main Pillars In High-Tech Production.
13.13.2 Pre-COVID-19 Market Scenario
13.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.14 Rest of Europe Market Analysis
13.14.1 Outsourcing Has Increased Significantly In Rest Of Europe
13.14.2 Pre-COVID-19 Market Scenario
13.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14 LAMEA Market Size Estimation and Forecast
14.1 Regional Overview
14.1.1 Lack Of Substantial Expertise And Costly Capabilities Are Main Challenges In The Region
14.1.2 The Outbreak Of Coronavirus Has A Significant Effect On Third-Party Service Providers In Biotech And Pharmaceuticals
14.2 LAMEA Market Size Estimation and Forecast
14.2.1 Pre-COVID-19 Market Scenario
14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.3 Country Market Size Estimation and Forecast
14.3.1 Pre-COVID-19 Market Scenario
14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.4 LAMEA Market Size Estimation and Forecast By Type
14.4.1 Pre-COVID-19 Market Scenario
14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.5 LAMEA Market Size Estimation and Forecast By Personal Promotion
14.5.1 Pre-COVID-19 Market Scenario
14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.6 LAMEA Market Size Estimation and Forecast By Non- Personal Promotion
14.6.1 Pre-COVID-19 Market Scenario
14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.7 LAMEA Market Size Estimation and Forecast By Co-Promotion
14.7.1 Pre-COVID-19 Market Scenario
14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.8 LAMEA Market Size Estimation and Forecast By Therapeutic
14.8.1 Pre-COVID-19 Market Scenario
14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.9 Brazil Market Analysis
14.9.1 Brazil Is The Only Latin American Country To Be Ranked Among The World's Top Pharmaceutical Markets
14.9.2 Pre-COVID-19 Market Scenario
14.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.10 South Africa Market Analysis
14.10.1 The Pharmaceutical Market In South Africa Is The Biggest In Africa
14.10.2 Pre-COVID-19 Market Scenario
14.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.11 Saudi Arabia Market Analysis
14.11.1 Saudi Arabia is one of the most appealing markets in Middle East For Pharma Products
14.11.2 Pre-COVID-19 Market Scenario
14.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.12 Turkey Market Analysis
14.12.1 Government Initiative To Limit Importations And Boost The Local Production Of The Pharmaceutical Industries In Turkey
14.12.2 Pre-COVID-19 Market Scenario
14.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.13 UAE Market Analysis
14.13.1 The UAE Governments Are Also Focused On Minimising Their Reliance On Imported Pharmaceuticals
14.13.2 Pre-COVID-19 Market Scenario
14.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.14 Rest of LAMEA Market Analysis
14.14.1 The Value Of Commercial Outsourcing Becomes Apparent In The Pharmaceutical Business In LAMEA
14.14.2 Pre-COVID-19 Market Scenario
14.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15 Competitive Landscape
15.1 Company Market Share Analysis
15.2 Key Business Strategy Analysis
15.3 New Product/Service Launch as the Key Business Strategy In the Global Market
15.4 Acquisition as the Key Business Strategy In the Global Market
15.5 Partnership as the Key Business Strategy In the Global Market
15.6 Collaboration as the Key Business Strategy In the Global Market
15.7 Expansion as the Key Business Strategy In the Global Market
15.8 Agreement as the Key Business Strategy In the Global Market
15.9 Contract as the Key Business Strategy In the Global Market
16 Leading Company Profiles
16.1 Apodi Healthcare Limited
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Company Product Benchmarking
16.2 CMIC Holdings Co., Ltd
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Company Financial Profile
16.2.4 Company Product Benchmarking
16.2.5 Company Recent Developments
16.3 Syneos Health Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Company Financial Profile
16.3.4 Company Product Benchmarking
16.3.5 Company Recent Developments
16.4 IQVIA Holdings Inc.
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Company Financial Profile
16.4.4 Company Product Benchmarking
16.4.5 Company Recent Developments
16.5 Marvecs GmbH
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Company Product Benchmarking
16.6 OnCall LLC
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Company Product Benchmarking
16.7 Publicis Groupe SA
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Company Financial Profile
16.7.4 Company Product Benchmarking
16.7.5 Company Recent Developments
16.8 Sofip
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Company Product Benchmarking
16.9 UDG Healthcare PLC
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Company Financial Profile
16.9.4 Company Product Benchmarking
16.9.5 Company Recent Developments
16.10 Amplity Health
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Company Product Benchmarking
16.10.4 Company Recent Developments
16.11 Granard Pharmaceuticals
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Company Product Benchmarking
16.12 Vanguard Pharma
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Company Product Benchmarking
16.13 GTS Solution
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Company Product Benchmarking
16.14 MaBiCo (Contract Sales Organization)
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Company Product Benchmarking
16.15 Sales Partnerships Inc.
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Company Product Benchmarking
16.16 QFR Solutions
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Company Product Benchmarking
17 Conclusion and Recommendations
17.1 Concluding Remarks
17.2 Recommendations
18 Glossary Terms
18.1 List Of Other Notable Player
18.2 List of Organization
List of Tables
Table 1. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 2. Global Pharma Contract Sales Market Snapshot, 2021 & 2031 (US$million, CAGR %)
Table 3. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 4. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 5. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 6. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 7. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 8. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 9. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 10. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 11. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 12. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 13. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 14. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 15. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 16. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 17. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 18. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 19. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 20. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 21. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 22. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 23. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 24. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 25. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 26. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 27. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 28. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 29. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 30. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 31. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 32. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 33. Global Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 34. Global Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 35. Global Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 36. Global Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 37. Global Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 38. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 39. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 40. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 41. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 42. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 43. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 44. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shaped Recovery)
Table 45. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shaped Recovery)
Table 46. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shaped Recovery)
Table 47. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shaped Recovery)
Table 48. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 49. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 50. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 51. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 52. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 53. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 54. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 55. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 56. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 57. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 58. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 59. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 60. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 61. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 62. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 63. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 64. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 65. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 66. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 67. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 68. North America Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 69. North America Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 70. North America Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 71. North America Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 72. North America Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 73. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 74. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 75. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 76. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 77. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 78. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 79. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 80. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 81. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 82. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 83. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 84. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 85. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 86. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 87. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 88. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 89. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 90. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 91. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 92. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 93. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 94. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 95. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 96. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 97. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 98. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 99. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 100. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 101. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 102. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 103. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 104. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 105. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 106. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 107. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 108. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 109. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 110. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 111. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 112. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 113. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 114. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 115. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 116. Asia-Pacific Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 117. Asia-Pacific Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 118. Asia-Pacific Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 119. Asia-Pacific Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 120. Asia-Pacific Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 121. China Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 122. China Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 123. China Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 124. China Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 125. China Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 126. India Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 127. India Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 128. India Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 129. India Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 130. India Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 131. Japan Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 132. Japan Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 133. Japan Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 134. Japan Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 135. Japan Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 136. South Korea Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 137. South Korea Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 138. South Korea Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 139. South Korea Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 140. South Korea Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 141. Australia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 142. Australia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 143. Australia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 144. Australia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 145. Australia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 146. Rest of Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 147. Rest of Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 148. Rest of Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 149. Rest of Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 150. Rest of Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 151. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 152. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 153. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 154. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 155. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 156. Europe Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 157. Europe Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shaped Recovery)
Table 158. Europe Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shaped Recovery)
Table 159. Europe Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shaped Recovery)
Table 160. Europe Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shaped Recovery)
Table 161. Europe Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 162. Europe Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 163. Europe Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 164. Europe Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 165. Europe Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 166. Europe Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 167. Europe Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 168. Europe Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 169. Europe Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 170. Europe Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 171. Europe Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 172. Europe Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 173. Europe Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 174. Europe Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 175. Europe Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 176. Europe Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 177. Europe Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 178. Europe Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 179. Europe Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 180. Europe Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 181. Europe Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 182. Europe Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 183. Europe Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 184. Europe Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 185. Europe Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 186. Germany Pharma Contract Sales Market by Country 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 187. Germany Pharma Contract Sales Market by Country 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 188. Germany Pharma Contract Sales Market by Country 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 189. Germany Pharma Contract Sales Market by Country 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 190. Germany Pharma Contract Sales Market by Country 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 191. UK Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 192. UK Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 193. UK Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 194. UK Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 195. UK Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 196. France Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 197. France Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 198. France Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 199. France Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 200. France Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 201. Italy Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 202. Italy Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 203. Italy Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 204. Italy Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 205. Italy Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 206. Spain Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 207. Spain Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 208. Spain Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 209. Spain Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 210. Spain Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 211. Rest of Europe Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 212. Rest of Europe Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 213. Rest of Europe Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 214. Rest of Europe Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 215. Rest of Europe Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 216. LAMEA Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 217. LAMEA Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 218. LAMEA Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 219. LAMEA Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 220. LAMEA Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 221. LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 222. LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V-shaped Recovery)
Table 223. LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery)
Table 224. LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery)
Table 225. LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery)
Table 226. LAMEA Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 227. LAMEA Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 228. LAMEA Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 229. LAMEA Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 230. LAMEA Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 231. LAMEA Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 232. LAMEA Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 233. LAMEA Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 234. LAMEA Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 235. LAMEA Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 236. LAMEA Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 237. LAMEA Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 238. LAMEA Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 239. LAMEA Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 240. LAMEA Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 241. LAMEA Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 242. LAMEA Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 243. LAMEA Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 244. LAMEA Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 245. LAMEA Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 246. LAMEA Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 247. LAMEA Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 248. LAMEA Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 249. LAMEA Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 250. LAMEA Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 251. Brazil Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 252. Brazil Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 253. Brazil Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 254. Brazil Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 255. Brazil Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 256. South Africa Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 257. South Africa Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 258. South Africa Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 259. South Africa Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 260. South Africa Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 261. Saudi Arabia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 262. Saudi Arabia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 263. Saudi Arabia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 264. Saudi Arabia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 265. Saudi Arabia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 266. Turkey Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 267. Turkey Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 268. Turkey Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 269. Turkey Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 270. Turkey Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 271. UAE Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 272. UAE Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 273. UAE Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 274. UAE Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 275. UAE Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 276. Rest of LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 277. Rest of LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 278. Rest of LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 279. Rest of LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 280. Rest of LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 281. New Product/Service Launch Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
Table 282. Acquisition Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
Table 283. Partnership Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
Table 284. Collaboration Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
Table 285. Expansion Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
Table 286. Agreement Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
Table 287. Contract Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
Table 288. Apodi Healthcare Limited.: Company Information
Table 289. Apodi Healthcare Limited.: Company Product and Service
Table 290. CMIC Holdings Co., Ltd.: Company Information
Table 291. CMIC Holdings Co., Ltd.: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 292. CMIC Holdings Co., Ltd.: Company Service Benchmarking
Table 293. CMIC Holdings Co., Ltd.: Company Recent Developments till Apr,2021
Table 294. Syneos Health Inc.: Company Information
Table 295. Syneos Health Inc.: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 296. Syneos Health Inc.: Company Product and Service Benchmarking
Table 297. Syneos Health Inc.: Company Recent Developments till May,2021
Table 298. IQVIA Holdings Inc.: Company Information
Table 299. IQVIA Holdings Inc.: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 300. IQVIA Holdings Inc.: Company Product and Service Benchmarking
Table 301. IQVIA Holdings Inc.: Company Recent Developments till Feb,2021
Table 302. Marvecs GmbH .: Company Information
Table 303. Marvecs GmbH .: Company Product and Service Benchmarking
Table 304. Oncall LLC.: Company Information
Table 305. OnCall LLC.: Company Product and Service Benchmarking
Table 306. Publicis Groupe SA .: Company Information
Table 307. Publicis Groupe SA Revenue 2016-2020 (US$Mn, AGR %)
Table 308. Publicis Groupe SA Product and Service
Table 309. Publicis Groupe SA Recent Developments till Apr,2021
Table 310. Sofip: Company Information
Table 311. Sofip: Company Product and Service Benchmarking
Table 312. UDG Healthcare PLC: Company Information
Table 313. UDG Healthcare PLC: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 314. UDG Healthcare PLC: Company Product and Service
Table 315. UDG Healthcare PLC.: Company Recent Developments till Feb,2021
Table 316. Amplity Health.: Company Information
Table 317. Amplity Health.: Company Product and Service Benchmarking
Table 318. Amplity Health.: Company Recent Developments till Feb,2021
Table 319. Granard Pharmaceuticals.: Company Information
Table 320. Granard Pharmaceuticals: Company Product and Service
Table 321. Vanguard Pharma.: Company Information
Table 322. Vanguard Pharma.: Company Product and Service
Table 323. GTS Solution : Company Information
Table 324. GTS Solution : Company Product and Service
Table 325. MaBiCo (Contract Sales Organization) .: Company Information
Table 326. MaBiCo (Contract Sales Organization) .: Company Product and Service
Table 327. Sales Partnerships Inc..: Company Information
Table 328. Sales Partnerships Inc..: Company Product and Service
Table 329. QFR Solutions.: Company Information
Table 330. QFR Solutions.: Company Product and Service
Table 331. Glossary Terms
List of Figures
Figure 1. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%))
Figure 2. Global Pharma Contract Sales Market Segmentation
Figure 3. SWOT Analysis
Figure 4. PEST Analysis
Figure 5. Porter Five Forces Analysis
Figure 6. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%))
Figure 7. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 8. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 9. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 10. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 11. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%))
Figure 12. Global Pharma contract sales Market by Region, 2021, 2026, 2031 (%)
Figure 13. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 14. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 15. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 16. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 17. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))
Figure 18. Global pharma contract salesMarket by EOR Type, 2021, 2026, 2031 (%)
Figure 19. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 20. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 21. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 22. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 23. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))
Figure 24. Global Pharma contract sales EOR Market by Personal Promotion, 2021, 2026, 2031 (%)
Figure 25. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 26. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 27. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 28. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) (L-Shape Recovery)
Figure 29. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))
Figure 30. Global Pharma Contract Sales Market by non-Personal Promotion, 2021, 2026, 2031 (%)
Figure 31. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 32. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 33. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 34. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 35. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))
Figure 36. Global Pharma Contract sales Market by Co-Promotion, 2021, 2026, 2031 (%)
Figure 37. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 38. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 39. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 40. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 41. Global Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))
Figure 42. Global Pharma Contract sales Market by Theraputic, 2021, 2026, 2031 (%)
Figure 43. Global Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
Figure 44. Global Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
Figure 45. Global Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
Figure 46. Global Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
Figure 47. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))
Figure 48. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
